# A Study of Ginsenoside H Dripping Pills for Advanced Non-Small Cell Lung Cancer (NSCLC)

> **NCT02714608** · PHASE2 · UNKNOWN · sponsor: **Tasly Pharmaceuticals, Inc.** · enrollment: 144 (estimated)

## Conditions studied

- Non-small Cell Lung Cancer (NSCLC)

## Interventions

- **DRUG:** Ginsenoside H dripping pills
- **DRUG:** Ginsenoside H dripping pills+Placebo
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02714608
- **Lead sponsor:** Tasly Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-05
- **Primary completion:** 2018-05
- **Final completion:** 2018-12
- **Target enrollment:** 144 (ESTIMATED)
- **Last updated:** 2017-03-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02714608

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02714608, "A Study of Ginsenoside H Dripping Pills for Advanced Non-Small Cell Lung Cancer (NSCLC)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02714608. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*